Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. Latin America is a market with a significant growth rate for conjugate vaccines. The conjugate vaccine market in Latin America is expected to grow at a CAGR of 20.4% leading to revenue of USD 5.43 Bn by 2023. By volume, it is anticipated to reach 839.21 Million units by 2023, expanding at a CAGR of 20.19%.